HIGHLIGHTS
- who: Dan Ouyang and colleagues from the School of Chinese Medicine, Hunan University of Chinese Medicine, Changsha, China, Hunan Provincial Key Laboratory of have published the paper: Effectiveness and Safety of Iguratimod Monotherapy or Combined With Methotrexate in Treating Rheumatoid Arthritis: A Systematic Review and Meta-Analysis, in the Journal: (JOURNAL) of 15/03/2022
- what: A large multicenter randomized controlled trial was conducted to evaluate the effectiveness and safety of IGU alone or in combination with MTX. The overall goal of RA treatment is to control symptoms and prevent disease progression. 3.3.4 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.